Suma Khazmo

Suma J. Khazmo is a visionary leader who leverages her extensive global network to drive innovation and social impact. With a focus on healthcare, particularly cancer drug development and regenerative medicine, she is dedicated to improving lives through cutting-edge medical advancements. Her leadership philosophy is rooted in the principles of sustainability, innovation, and social justice, making her a transformative figure in the global business landscape. Affiliations: Advisory board member is a results-driven business leader and biotechnology expert with over 16 years of global experience in biotechnology, regenerative medicine, healthcare, finance, trade finance, and international law. She leads Tryton Investments / UK, managing a portfolio of companies and projects across multiple sectors. She holds advanced degrees in international law, relations, and media, and has dedicated her career to innovation, policy-making, and sustainable development. She has built strong relationships with governments, royal families, and global organizations, and has held executive and board positions providing advisory services in her fields of expertise. Through these roles, she drives impactful progress in multiple areas, with a particular emphasis on healthcare, cancer research, regenerative medicine, women empowerment, and promoting social impact investments locally, regionally, and internationally. She has expertise in cross-border trade, import and export, and market expansion. She is recognized for her skills in strategic business planning, alliance development, logistics, and international commodity financing, providing valuable insights into effective market entry strategies at local, regional, and international levels.